STOCK TITAN

T. Rowe Price (ACLX) reports 18.3% beneficial stake in Arcellx

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

T. Rowe Price Investment Management, Inc. reported beneficial ownership of 10,560,425 shares of Arcellx Inc.18.3% of the class as of the event date December 31, 2025.

The firm has sole power to vote 10,266,287 shares and sole power to dispose of 10,554,934 shares, with no shared voting or dispositive power. It states the shares were acquired and are held in the ordinary course of business, not to influence control of Arcellx.

Positive

  • None.

Negative

  • None.





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G





SCHEDULE 13G



T. Rowe Price Investment Management, Inc.
Signature:Ellen York
Name/Title:Vice President
Date:02/17/2026

FAQ

How many Arcellx (ACLX) shares does T. Rowe Price Investment Management own?

T. Rowe Price Investment Management reports beneficial ownership of 10,560,425 Arcellx common shares. This stake represents a significant holding and is disclosed in a Schedule 13G/A, which is used for institutional investors with a generally passive investment intent.

What percentage of Arcellx (ACLX) does T. Rowe Price Investment Management hold?

T. Rowe Price Investment Management holds 18.3% of Arcellx’s common stock. This percentage is based on the shares outstanding referenced in the filing and reflects a sizable institutional position that must be reported under U.S. securities ownership disclosure rules.

Does T. Rowe Price Investment Management control Arcellx (ACLX) through this stake?

T. Rowe Price Investment Management states the Arcellx shares were acquired and are held in the ordinary course of business. It affirms they were not acquired for the purpose of changing or influencing control of Arcellx, consistent with a passive Schedule 13G filing.

What voting power does T. Rowe Price Investment Management have over Arcellx (ACLX) shares?

The firm reports sole voting power over 10,266,287 shares of Arcellx common stock and no shared voting power. This means it alone can vote those shares, subject to any internal or client mandates, as disclosed in the Schedule 13G/A.

What dispositive power does T. Rowe Price Investment Management have in Arcellx (ACLX)?

T. Rowe Price Investment Management reports sole dispositive power over 10,554,934 shares and no shared dispositive power. Sole dispositive power indicates authority to decide whether and when to sell those shares, consistent with its role as an investment manager.

Why did T. Rowe Price Investment Management file a Schedule 13G/A for Arcellx (ACLX)?

The Schedule 13G/A was filed because its Arcellx holdings exceeded 5% of the company’s common stock. The firm certifies that the securities were acquired and are held in the ordinary course of business, not to influence control, which aligns with 13G passive reporting.
ARCELLX INC

NASDAQ:ACLX

ACLX Rankings

ACLX Latest News

ACLX Latest SEC Filings

ACLX Stock Data

6.59B
48.51M
Biotechnology
Biological Products, (no Diagnostic Substances)
Link
United States
REDWOOD CITY